Taxol-resistance-associated gene-3 (TRAG-3/CSAG2) expression is predictive for clinical outcome in ovarian carcinoma patients

Virchows Archiv

Volumn 450, Issue 2, 2007, Pages 187-194

  Materna, Verena ^a   Surowiak, Paweł ^a,b,c   Kaplenko, Irina ^d   Spaczyński, Marek ^d   Duan, Zhenfeng ^e   Zabel, Maciej ^b,d   Dietel, Manfred ^a   Lage, Hermann ^a  

^a Charité Campus Benjamin Franklin Medical Center   (Germany)

^b WROCLAW MEDICAL UNIVERSITY   (Poland)

^c Dolnoslaskie Centrum Onkologii Wroclaw   (Poland)

^d POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^e MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Chemotherapy; CSAG2; Ovarian carcinoma; Paclitaxel; TRAG 3

Indexed keywords

CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; GENE PRODUCT; PACLITAXEL; TAXOL RESISTANCE ASSOCIATED GENE 3 PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER GROWTH; CLINICAL ARTICLE; CLINICAL OBSERVATION; CONTROLLED STUDY; CYTOREDUCTIVE SURGERY; FEMALE; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LAPAROTOMY; MULTIMODALITY CANCER THERAPY; OVARY CARCINOMA; OVERALL SURVIVAL; PRIORITY JOURNAL;

ADULT; AGED; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; NEOPLASM PROTEINS; OVARIAN NEOPLASMS; SURVIVAL RATE;

EID: 33847094204     PISSN: 09456317     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00428-006-0346-7     Document Type: Article

References (26)

1. Ambudkar SV, Kimchi-Sarfaty C, Sauna ZE, Gottesman MM (2003) P-glycoprotein: from genomics to mechanism. Oncogene 22:7468-7485
2. Chen Z, Zhu B, Wu Y (2002) Expression of TRAG-3 antigen in non-small-cell lung carcinomas. Lung Cancer 38:101-102
3. Duan Z, Duan Y, Lamendola DE, Yusuf RZ, Naeem R, Penson RT, Seiden MV (2003) Overexpression of MAGE/GAGE genes in paclitaxel/doxorubicin-resistant human cancer cell lines. Clin Cancer Res 9:2778-2785
4. Duan Z, Feller AJ, Toh HC, Makastorsis T, Seiden MV (1999) TRAG-3, a novel gene, isolated from taxol-resistant ovarian carcinoma cell line. Gene 229:75-81
5. Feller AJ, Duan Z, Penson R, Toh HC, Seiden MV (2000) TRAG-3, a novel cancer/testis antigen, is overexpressed in the majority of melanoma cell lines and malignant melanoma. Anticancer Res 20:4147-4151
6. Giannakakou O, Sackett DL, Kang YK, Zhan Z, Buters JT, Fojo T, Poruchynsky MS (1997) Paclitaxel-resistant human ovarian cancer cells have mutant beta-tubulins that exhibit impaired paclitaxel-driven polymerization. J Biol Chem 272:17118-17125
7. Haber M, Burkhart CA, Regl DL, Madafiglio J, Norris MD, Horwitz SB (1995) Altered expression of Mbeta2, the class II beta-tubulin isotype, in a murine J774.2 cell line with a high level of taxol resistance. J Biol Chem 270:31269-31275
8. Lage H, Dietel M (1997) Cloning and characterization of human cDNAs encoding a protein with high homology to rat intestinal development protein OCI-5. Gene 188:151-156
9. Lin C, Mak S, Meitner PA, Wolf JM, Bluman EM, Block JA, Terek RM (2002) Cancer/testis antigen CSAGE is concurrently expressed with MAGE in chondrosarcoma. Gene 285:269-278
10. Materna V, Pleger J, Hoffmann U, Lage H (2004) RNA expression of MDR1/P-glycoprotein, DNA-topoisomerase I, and MRP2 in ovarian carcinoma patients: correlation with chemotherapeutic response. Gynecol Oncol 94:152-160
11. McGuire WP 3rd, Markman M (2003) Primary ovarian cancer chemotherapy: current standards of care. Br J Cancer 89:53-58
12. Nimmrich I, Erdmann S, Melchers U, Finke U, Hentsch S, Moyer MP, Hoffmann I, Muller O (2000) Seven genes that are differentially transcribed in colorectal tumor cell lines. Cancer Lett 160:37-43
13. Ohta M, Tanaka F, Sadanaga N, Yamaguchi H, Inoue H, Mori M (2006) Expression of the TRAG-3 gene in human esophageal cancer: The frequent synchronous expression of MAGE-3 gene. Oncol Rep 15:1529-1532
14. Ozols RF, Schwartz PE, Eifel PJ (2001) Ovarian cancer, fallopian tube carcinoma and peritoneal carcinoma. In: De Vita Jr. VT, Hellman S, Rosenberg SA (eds) Cancer: principles & practice of oncology, 6th edn. Lippincott-Raven, Philadelphia, pp 1597-1632
15. Remmele W, Stegner HE (1987) Recommendation for uniform definition of an immunoreactive score (IRS) for immunohistochemical estrogen receptor detection (ER-ICA) in breast cancer tissue [Article in German]. Pathologe 8:138-140
16. Rowinsky EK, Donehower RC (1995) Paclitaxel (taxol). N Engl J Med 332:1004-1014
17. Scheffer GL, Wijngaard PL, Flens MJ, Izquierdo MA, Slovak ML, Pinedo HM, Meijer CJ, Clevers HC, Scheper RJ (1995) The drug resistance-related protein LRP is the human major vault protein. Nat Med 1:578-582
18. Shimizu Y, Kamoi S, Amada S, Akiyama F, Silverberg SG (1998) Toward the development of a universal grading system for ovarian epithelial carcinoma. Cancer 82:893-901
19. Sobin LH, Wittekind C (eds) (2002) TNM classification of malignant tumors (UICC). Wiley-Liss, New York
20. Stewart BW, Kleihues P (eds) (2003) World cancer report. IARC, Lyon, pp 220-222
21. Surowiak P, Materna M, Denkert C, Kaplenko I, Spaczynski M, Dietel M, Zabel M, Lage H (2006) Significance of cyclooxygenase 2 and MDR1/P-glycoprotein coexpression in ovarian cancers. Cancer Lett 235:272-280
22. Therasse P, Arbuck SG, Eisenhauer EA, Wanders J, Kaplan RS, Rubinstein L, Verweij J, Van Glabbeke M, van Oosterom AT, Christian MC, Gwyther SG (2000) New guidelines to evaluate the response to treatment in solid tumors. J Natl Cancer Inst 92: 205-216
23. Wichert A, Stege A, Midorikawa Y, Holm PS, Lage H (2004) Glypican-3 is involved in cellular protection against mitoxantrone in gastric carcinoma cells. Oncogene 23:945-955
24. Wu Y, Zhao T, Ni B, Zou L, Liu H, Zhu B (2003) Expression of TRAG-3 in breast cancer. Int J Cancer 107:167-168
25. Yao X, Hu J, Li T, Yang Y, Sun Z, Ulaner GA, Vu TH, Hoffman AR (2004) Epigenetic regulation of the taxol resistance-associated gene TRAG-3 in human tumors. Cancer Genet Cytogenet 151:1-13
26. Zhu B, Chen Z, Cheng X, Wu Y (2002) Induction of TRAG-3 expression in A549 lung adenocarcinoma cell line by 5-aza-2′ deoxyazacytidine. Lung Cancer 38:321-322